Analysis of COVID-19 Research Status in the Field of Traditional Chinese Medicine from the Perspective of Bibliometrics
- DOI
- 10.2991/978-94-6463-124-1_68How to use a DOI?
- Keywords
- COVID-19; Traditional Chinese medicine; Bibliometric; Visual analysis; VOS viewer
- Abstract
Objective: To explore the research status, theme changes and regular characteristics of novel coronavirus in the field of traditional Chinese medicine. Methods: Chinese and English literatures related to COVID-19 in the field of traditional Chinese medicine were retrieved, and the contents of the articles were clustered and analyzed. Results: There were 4,326 Chinese and 1, 040 English documents which met the requirements, and the time span was from January 1, 2020 to June 16, 2022. Conclusion: The research topics of TCM are characterized by stages, close cooperation among research groups, and the degree of integration of traditional Chinese and western medicine is gradually increasing, but there are still some deficiencies in the dissemination.
- Copyright
- © 2023 The Author(s)
- Open Access
- Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
Cite this article
TY - CONF AU - Shiwen Wang AU - Yuanquan Pan AU - Songqing Bai AU - Chenyan Yang AU - Qi Shao PY - 2023 DA - 2023/03/29 TI - Analysis of COVID-19 Research Status in the Field of Traditional Chinese Medicine from the Perspective of Bibliometrics BT - Proceedings of the 2022 3rd International Conference on Big Data Economy and Information Management (BDEIM 2022) PB - Atlantis Press SP - 584 EP - 593 SN - 2352-5428 UR - https://doi.org/10.2991/978-94-6463-124-1_68 DO - 10.2991/978-94-6463-124-1_68 ID - Wang2023 ER -